Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2026-01-05 @ 5:32 PM
Study NCT ID:
NCT04779957
Status:
RECRUITING
Last Update Posted:
2024-08-27
First Post:
2021-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy
Sponsor:
University Hospital, Toulouse
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-26
First Submit QC Date:
None
Study First Post Date:
2021-03-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-26
Last Update Post Date:
2024-08-27
Last Update Post Date Type:
ACTUAL